ADC Therapeutics SA (ADCT)vsTeva Pharma Industries Ltd ADR (TEVA)
ADCT
ADC Therapeutics SA
$1.10
-0.90%
HEALTHCARE · Cap: $161.53M
TEVA
Teva Pharma Industries Ltd ADR
$34.71
+2.02%
HEALTHCARE · Cap: $37.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Teva Pharma Industries Ltd ADR generates 21812% more annual revenue ($17.35B vs $79.17M). TEVA leads profitability with a 9.0% profit margin vs -173.0%. TEVA earns a higher WallStSmart Score of 66/100 (B-).
ADCT
Avoid23
out of 100
Grade: F
TEVA
Strong Buy66
out of 100
Grade: B-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Earnings expanding 72.2% YoY
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -706.0% — below average capital efficiency
Revenue declined 9.5%
2.3% revenue growth
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : ADCT
The strongest argument for ADCT centers on Debt/Equity.
Bull Case : TEVA
The strongest argument for TEVA centers on EPS Growth, PEG Ratio. PEG of 0.91 suggests the stock is reasonably priced for its growth.
Bear Case : ADCT
The primary concerns for ADCT are EPS Growth, Market Cap, Return on Equity.
Bear Case : TEVA
The primary concerns for TEVA are Revenue Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 2.05 is elevated, increasing financial risk.
Key Dynamics to Monitor
ADCT profiles as a turnaround stock while TEVA is a value play — different risk/reward profiles.
ADCT carries more volatility with a beta of 1.88 — expect wider price swings.
TEVA is growing revenue faster at 2.3% — sustainability is the question.
ADCT generates stronger free cash flow (-30M), providing more financial flexibility.
Bottom Line
TEVA scores higher overall (66/100 vs 23/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ADC Therapeutics SA
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors. The company is headquartered in Epalinges, Switzerland.
Visit Website →Teva Pharma Industries Ltd ADR
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?